BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 22957306PMCID PMC3433105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins

  2011cited by this paper
• Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.

  2010cited by this paper
• BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer

  2010cited by this paper
• BRCA1 16 years later: nuclear import and export processes

  2010cited by this paper
• The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome.

  2010cited by this paper
• BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

  2010cited by this paper
• Common variants in the UBC9 gene encoding the SUMO‐conjugating enzyme are associated with breast tumor grade

  2009cited by this paper
• Expression of a novel marker, Ubc9, in squamous cell carcinoma of the head and neck

  2009cited by this paper
• Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner

  2009cited by this paper
• A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.

  2009cited by this paper
• The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress

  2009cited by this paper
• Mitochondrial localization, ELK‐1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins

  2009cited by this paper
• Expression of BRCA1 protein in breast cancer and its prognostic significance.

  2008cited by this paper
• E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks

  2008cited by this paper
• Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation

  2007cited by this paper
• Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.

  2007cited by this paper
• Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase

  2007cited by this paper
• Dual Role for SUMO E2 Conjugase Ubc9 in Modulating the Transforming and Growth-promoting Properties of the HMGA1b Architectural Transcription Factor*

  2007cited by this paper
• Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins

  2007cited by this paper
• Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.

  2007cited by this paper
• BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers

  2007cited by this paper
• SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy

  2007cited by this paper
• Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins.

  2007cited by this paper
• Ubiquitin-dependent Proteolytic Control of SUMO Conjugates*

  2007cited by this paper
• Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells.

  2006cited by this paper
• BRCA1 regulation of transcription.

  2006cited by this paper
• The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers

  2006cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• SUMO: a history of modification.

  2005cited by this paper
• Protein modification by SUMO.

  2004cited by this paper
• FHL2, UBC9, and PIAS1 are Novel Estrogen Receptor α‐Interacting Proteins

  2004cited by this paper
• FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins.

  2004cited by this paper
• Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs.

  2004cited by this paper
• Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria.

  2004cited by this paper
• Nuclear and unclear functions of SUMO

  2003cited by this paper
• Versatile protein tag, SUMO: Its enzymology and biological function

  2002cited by this paper
• BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export*

  2002cited by this paper
• Loss of nuclear BRCA1 localization in breast carcinoma is age dependent

  2002cited by this paper
• c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells

  2001cited by this paper
• BRCA1 carries tumor suppressor activity distinct from that of p53 and p21

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Importin 13: a novel mediator of nuclear import and export

  2001cited by this paper
• Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.

  2001cited by this paper
• Preclinical studies of a new generation retroviral vector for ovarian cancer BRCA1 gene therapy.

  2000cited by this paper
• BRCA1-associated growth arrest is RB-dependent.

  1999cited by this paper
• Frequency of germline and somatic BRCA1 mutations in ovarian cancer.

  1998cited by this paper
• Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.

  1997cited by this paper
• Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b

  1997cited by this paper
• BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases

  1997cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• Induction of apoptosis by the tumor suppressor protein BRCA1.

  1996cited by this paper
• Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells.

  1996cited by this paper
• Somatic mutations in the BRCA1 gene in sporadic ovarian tumours

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper

• Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases

  2024cites this paper
• BRCA1 Mutation Leads to Deregulated Ubc9 Levels which Triggers Proliferation and Migration of Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells

  2017cites this paper
• SUMOylation regulates focal adhesions in cancer cell migration

  2017cites this paper
• Customized Chemotherapy in Advanced Gastric Cancer

  2017cites this paper
• A pre-clinical investigation of the anti-cancer effects of the frankincense constituent AKBA on ovarian cancer cells

  2017cites this paper
• BRCA1 Mutation Leads to Deregulated Ubc9 Levels which Triggers Proliferation and Migration of Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells

  2016cites this paper
• E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes

  2016cites this paper
• Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites.

  2015cites this paper
• A Novel Pathway that Links Caveolin-1 Down-Regulation to BRCA1 Dysfunction in Serous Epithelial Ovarian Cancer Cells

  2014cites this paper
• Epithelial ovarian cancer: An overview.

  2014cites this paper
• Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer

  2014influential citation
• Characterization and Targeting of the Aldehyde Dehydrogenase Subpopulation in Ovarian Cancer

  2013cites this paper
• Ubiquitin-Conjugating Enzyme 9 Promotes Epithelial Ovarian Cancer Cell Proliferation in Vitro

  2013cites this paper